OREANDA-NEWS. uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that members of its leadership team will present an overview of the company's programs and progress at several upcoming investor conferences.  These meetings include the following:

  • CITI 11th Annual Biotech Conference
    Venue: The Mandarin Oriental Hotel, Boston MA 
    Presenter: Harald Petry, Ph.D., Chief Scientific Officer
    Title, Date and Time: "Gene Therapy, A New Era" panel discussion, Wednesday, September 7, 1:00 p.m. EDT 
     
  • Rodman & Renshaw 18th Annual Global Investment Conference
    Venue:     The Lotte New York Palace Hotel, New York City
    Presenter: Matthew Kapusta, Chief Financial Officer
    Date and Time: Monday, September 12, 3:50 p.m. EDT
    Webcast: http://wsw.com/webcast/rrshq26/qure
  • Leerink Partners Rountable Series: Rare Disease & Immuno- Oncology
    Venue:     The Lotte New York Palace Hotel, New York City
    Presenter: Christian Meyer, M.D., Chief Medical Officer
    Date and Time: Wednesday, September 28, 2:35 p.m. EDT
    Webcast: http://wsw.com/webcast/leerink27/qure

The webcasts for the Rodman & Renshaw 18th Annual Global Investment Conference and the Leerink Partners Roundtable Series, also can be accessed by the link displayed in the "Events" section on the "Media" page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live events and archived on the uniQure website for at least 30 days following the webcast.

About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases.